Stereotaxis surgical robot earns regulatory nod in China
November 25, 2024
Stereotaxis (NYSE:STXS) announced today that its Genesis surgical robot received regulatory approval in China.
Stereotaxis (NYSE:STXS) announced today that its Genesis surgical robot received regulatory approval in China.
Globus Medical (NYSE:GMED) announced that launched its ExcelsiusHub navigation system for robotic surgical procedures.
SEOUL, South Korea, Nov. 25, 2024 /PRNewswire/ — Neurophet, an artificial intelligence (AI) solution company for brain disease, announced on the 25th that its brain MRI analysis software “Neurophet AQUA”, has obtained 510(k) clearance from U.S. Food and Drug Administration (FDA) for its newly integrated multiple sclerosis (MS) analysis functionality.
MILPITAS, Calif., Nov. 25, 2024 /PRNewswire/ — LifeSignals, Inc. today announced that the UbiqVue 2A Multiparameter System has received FDA Class II 510(k) clearance, marking a significant milestone in continuous wireless patient monitoring for population health management.